These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11753022)

  • 1. Advances in neurobiology of the neuromuscular junction: implications for the anesthesiologist.
    Naguib M; Flood P; McArdle JJ; Brenner HR
    Anesthesiology; 2002 Jan; 96(1):202-31. PubMed ID: 11753022
    [No Abstract]   [Full Text] [Related]  

  • 2. The neuromuscular junction: recent developments.
    Bowman WC
    Eur J Anaesthesiol; 1985 Mar; 2(1):59-93. PubMed ID: 2410263
    [No Abstract]   [Full Text] [Related]  

  • 3. Seronegative myasthenia gravis. Evidence for plasma factor(s) interfering with acetylcholine receptor function.
    Vincent A; Li Z; Hart A; Barrett-Jolley R; Yamamoto T; Burges J; Wray D; Byrne N; Molenaar P; Newsom-Davis J
    Ann N Y Acad Sci; 1993 Jun; 681():529-38. PubMed ID: 8395163
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of a putative nicotinic acetylcholine receptor in mammalian brain.
    Morley BJ; Kemp GE
    Brain Res; 1981 Aug; 228(1):81-104. PubMed ID: 7023616
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of synaptic transmission in the neuromuscular junction using a continuum finite element model.
    Smart JL; McCammon JA
    Biophys J; 1998 Oct; 75(4):1679-88. PubMed ID: 9746510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of storage vesicles in synaptic transmission.
    Marchbanks RM
    Symp Soc Exp Biol; 1979; 33():251-76. PubMed ID: 230607
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pathogenesis and pathophysiology of myasthenia gravis--electrophysiological, ultrastructural and immunological aspects of neuromuscular junctions (author's transl)].
    Takamori M; Tsujihata M; Ide Y; Eguchi K; Mine M
    No To Shinkei; 1980 Sep; 32(9):891-908. PubMed ID: 6254548
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunology of acetylcholine receptors in relation to myasthenia gravis.
    Vincent A
    Physiol Rev; 1980 Jul; 60(3):756-824. PubMed ID: 6248907
    [No Abstract]   [Full Text] [Related]  

  • 9. A non-immunogenic myasthenia gravis model and its application in a study of transsynaptic regulation at the neuromuscular junction.
    Molenaar PC; Oen BS; Plomp JJ; Van Kempen GT; Jennekens FG; Hesselmans LF
    Eur J Pharmacol; 1991 Apr; 196(1):93-101. PubMed ID: 1874282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuum simulations of acetylcholine diffusion with reaction-determined boundaries in neuromuscular junction models.
    Cheng Y; Suen JK; Radić Z; Bond SD; Holst MJ; McCammon JA
    Biophys Chem; 2007 May; 127(3):129-39. PubMed ID: 17307283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into possible skeletal muscle nicotinic acetylcholine receptor (AChR) changes in some congenital myasthenias from physiological studies, point mutations, and subunit substitutions of the AChR.
    Kaminski HJ; Ruff RL
    Ann N Y Acad Sci; 1993 Jun; 681():435-50. PubMed ID: 7689311
    [No Abstract]   [Full Text] [Related]  

  • 12. [The role of cholesterol in exo- and endocytosis of the synaptic vesicles at the frog motor nerve terminal].
    Petrov AM; kasimov MR; Giniatullin AR; Tarakanova OI; Zefirov AL
    Ross Fiziol Zh Im I M Sechenova; 2009 Jul; 95(7):762-72. PubMed ID: 19803462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clustering of nicotinic acetylcholine receptors: from the neuromuscular junction to interneuronal synapses.
    Huh KH; Fuhrer C
    Mol Neurobiol; 2002 Feb; 25(1):79-112. PubMed ID: 11890459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An inevitable gate for quantal acetylcholine release.
    Dunant Y; Israël M
    Neurochem Int; 1997 Dec; 31(6):763-7. PubMed ID: 9413837
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurobiology. The constant junction.
    Salpeter MM
    Science; 1999 Oct; 286(5439):424-5. PubMed ID: 10577204
    [No Abstract]   [Full Text] [Related]  

  • 16. Schwann cells modify expression of acetylcholinesterase and butyrylcholinesterase at rat neuromuscular junctions.
    Chapron J; De La Porte S; Delépine L; Koenig J
    Eur J Neurosci; 1997 Feb; 9(2):260-70. PubMed ID: 9058046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging the neuromuscular junction over the past centuries.
    Lu J; Lichtman JW
    Sheng Li Xue Bao; 2007 Dec; 59(6):683-96. PubMed ID: 18157463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choline acetyltransferase and acetylcholinesterase. Their role in the causes of myasthenia gravis.
    Gentner DR; Rosenberg RN
    Arch Neurol; 1972 Dec; 27(6):521-5. PubMed ID: 4343459
    [No Abstract]   [Full Text] [Related]  

  • 19. Congenital myasthenic syndrome associated with paucity of synaptic vesicles and reduced quantal release.
    Walls TJ; Engel AG; Nagel AS; Harper CM; Trastek VF
    Ann N Y Acad Sci; 1993 Jun; 681():461-8. PubMed ID: 8395161
    [No Abstract]   [Full Text] [Related]  

  • 20. Acetylcholine receptor structure, function, and evolution.
    Stroud RM; Finer-Moore J
    Annu Rev Cell Biol; 1985; 1():317-51. PubMed ID: 2435309
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.